«Keywords Immunohistochemistry · Antibody labeling · Fluorescence microscopy · Fluorescent immunocytochemistry · Fluorescent immunohistochemistry ...»
Keywords Immunohistochemistry · Antibody labeling · Fluorescence microscopy · Fluorescent immunocytochemistry · Fluorescent immunohistochemistry · Indirect immunocytochemistry · Immunostaining
Antibody Molecules............................... 8
Making Antibodies................................ 10 Talking About Antibodies............................. 13 Finding and Getting Antibodies.......................... 14 Choice of Primary (1◦ ) Antibodies......................... 15 Antibodies Handling and Storing......................... 16 Recommended Storage Freezer, –20◦ C..................... 16 Recommended Storage Refrigerator, 4◦ C.................... 16 Introduction An antibody (Ab) is the key reagent of immunocytochemistry. To use antibodies effectively, consider their structure, function, and generation. Such basic knowledge about antibodies is essential to succeed in identifying suitable experimental design, ﬁnding antibodies, and trouble-shooting problems.
Immunocytochemistry takes advantage of three properties of antibodies:
1. Antibodies uniquely bind to a protein or other molecule.
2. Antibody binding to molecules is essentially permanent at physiological conditions.
3. New antibodies can be made tailored to new interesting molecules.
R.W. Burry, Immunocytochemistry, DOI 10.1007/978-1-4419-1304-3_2, C Springer Science+Business Media, LLC 2010 8 2 Antibodies Antibody Molecules An immune response generates antibodies or proteins called immunoglobulins (Igs).
Antibodies are further classiﬁed into multiple isotypes or classes (Table 2.1). In immunocytochemistry, the IgG isotype is preferred because its generation and binding is more consistent. IgM antibodies can be used if no other isotype is available.
The IgG molecules can be broken down into four subclasses, IgG1, IgG2, IgG3, and IgG4. In immunocytochemistry experiments, these subclasses do not matter for most species of animals, but they are important for antibodies generated in mouse monoclonal antibodies (IgG1, IgG2a, IgG2b, and IgG3), as we will see in later chapters.
In using antibodies, knowledge of the IgG structure is important (Fig. 2.1). IgG has a constant region and a variable region. The constant region contains speciesspeciﬁc sequences and the Fc portion that binds an Fc receptor (Fig. 2.1, clear end), which is found on circulating white cells, macrophages, and natural killer cells.
The Fc portion also has species-speciﬁc sites that are unique to the animal species Fig. 2.1 The antibody. An IgG antibody has a single constant region (white) with the Fc portion and the species-speciﬁc antigens. The variable region (gray) contains the Fab portion that binds the epitope portion of the antigen. The small protein, only in the variable region, is known as the light chain; the large protein that is part of the constant and variable region is the heavy chain. The IgG can be digested by the protease enzyme, papain, into an Fc end (constant end) and a Fab end (variable end) Antibody Molecules 9 in which the antibody was generated. Thus, generation of an antibody against IgG from rabbit will result in antibodies that bind the constant region from rabbit IgG only and not, for example, from mouse IgG.
Immunocytochemistry uses antibodies against IgGs. Antibodies or IgG molecules are generated to other IgG molecules by injecting puriﬁed IgG molecules from one species into another species. In the case of mouse IgG injected into rabbit, it will produce rabbit anti-mouse IgG antibodies. Antibodies made against an IgG will only bind to the constant region or Fab region of the IgG.
The variable end of the antibody contains the unique epitope-binding regions that give each antibody its speciﬁcity (Fig. 2.1, gray end). This variable region is the fraction antigen binding (Fab) portion. The unique conﬁguration of the Fab specifically binds the epitope. When an antigen is injected into a rabbit, the resulting antibodies against the antigen have Fab portions that are unique to the antigen, but the rest of the IgG is similar to other IgG molecules.
Each IgG antibody has two Fab ends, which can bind to two identical epitopes at the same time. The advantage of this bivalent epitope binding is that it can amplify the epitope detection. The orientation of the two epitopes is not restricted as there are hinge regions (Fig. 2.1) in the IgG molecule that connect the Fab portion to the Fc portion of the IgG. The hinge region allows movement and rotation of each individual Fab, thus facilitating binding to adjacent identical epitopes.
Heavy chains or long protein (Fig. 2.1, light and dark bars connected by a papainsensitive hinge) and light chains or short protein (Fig. 2.1, short dark bar) IgG molecules are made of two proteins that are held together by disulﬁde bonds of the amino acid cysteine (Fig. 2.1; S–S between bars).
The enzyme, papain, can digest the hinge regions of IgG and can generate two identical Fab portions and one Fc portion. The individual Fab portion can be used for immunocytochemistry, where single epitope-binding region is needed without species-speciﬁc binding.
An antigen is a protein, peptide, or molecule used to cause an immune response in an animal. The animal responds by making antibodies to individual epitopes located on the antigen. An individual antigen has multiple epitopes that can generate antibodies. In Fig. 2.2, the “&” represents an antigen and the light gray areas on the edge represent individual epitopes. An epitope can be an amino acid sequence on a Fig. 2.2 Antibody generation. Antigens are the molecules injected into animals that generate antibodies (“&” is an antigen). Epitopes are small parts of antigens that generate a speciﬁc antibody (short gray lines on “&” are epitopes). Here, six antibodies (small Ys) are generated to epitopes on the antigen “&.” Each different antibody is from a clone of B-cells (with numbers); each B-cell produces antibodies to only one epitope; some clones can produce antibodies to the same epitope as other clones (clones No. 1 and No. 4) 10 2 Antibodies denatured peptide or a several sequences on the surface of a folded protein. Animals frequently generate multiple antibodies to the same epitope (Fig. 2.2, clones 1 and 4). Also, an epitope on one protein might also exist on a different, unrelated protein because it has the same sequence or the same surface conﬁguration.
Making Antibodies An animal injected with an antigen will generate multiple antibodies to many epitopes. Antibodies are produced by B-cells and a single clone of B-cells produces antibodies to only a single epitope. Once a B-cell begins producing a single type of antibody, it will divide and give rise to many B-cells, all producing that single antibody to just one epitope; this is called a B-cell clone. Sometimes there are multiple clones of B-cells that produce antibodies to a single epitope (Fig. 2.3, clones 1 and 4). Parts of injected proteins and molecules make better antigens than others. As a result, some proteins do not generate many antibodies. An example is G-coupled receptors, a class of membrane receptors, that do not generate antibodies well.
Fig. 2.3 Polyclonal antibodies. An animal injected with an antigen will generate B-cell clones that can produce antibodies to multiple epitopes. The serum from the animal has different antibodies to these multiple clones, thus the name, polyclonal Polyclonal antibodies contain multiple clones of antibodies produced to different epitopes on the antigen. In Fig. 2.3, the serum from an immunized rabbit contains antibodies from six clones of B-cells. In serum from the rabbit, the six different clones of antibodies will increase the labeling of the antigen because there are multiple epitopes on the antigen. Polyclonal antibodies are in the form of serum from animals and are made in different species of large animals (rabbit, donkey, goat, sheep, and chicken). Chicken polyclonal antibodies are puriﬁed from unfertilized egg yolks, with the advantage that eggs are easy to collect and large amounts of an antibody can be isolated from a single chick.
Advantages of Polyclonal Antibody
Monoclonal antibodies, originally from one mouse, contain a single antibody from one clone of B-cells to a single epitope on the antigen. This procedure was ﬁrst described by Georges Kohler and Cesar Milstein, for which they received the Nobel Prize in 1984. Monoclonal antibodies are made by immunizing a mouse, and when antibodies are produced, the spleen of immunized mouse is removed (Fig. 2.4). The spleen cells are dissociated including the B-cells producing antibodies (Fig. 2.4, different gray levels). Because B-cells will not divide in culture, they must be fused with a continuously dividing cell line that produces antibodies. Such a cell line is the mouse myeloma cell line.
The spleen cells are fused with mouse myeloma cells to become a continuous hybridoma cell line. A continuous hybridoma cell line with multiple B-cell clones produces many different antibody clones indicated by the different gray levels of Fig. 2.4 Monoclonal antibodies. After injecting the antigen and generating several clones of antibodies, the spleen containing B-cells is removed. Hybridoma cells are made by fusing spleen B-cells with a myeloma cell culture line. To isolate the individual hybridoma cells producing one clone of antibody, the mixed hybridoma culture is highly diluted and plated in 96-well plates with one cell or less per well 12 2 Antibodies the cells in Fig. 2.4. Next, the population of hybridoma cells producing many antibodies is cloned in 96-well plates and each single B-cell clone of cultured cells produces one antibody. Individual clones producing a separate antibody are named by location in the 96-well plate (e.g., 5B12 plate 5, row B, column 12). One mouse spleen can give many different antibodies to different epitopes on the same antigen.
Monoclonal antibodies are raised in either tissue culture media, called supernatant, or generated from hybridoma cells injected into the peritoneal cavity (abdominal cavity), called ascites ﬂuid. Until recently, all monoclonal antibodies were generated exclusively from mice because of the limitations with generating good myeloma cell lines for other species of animals. Rabbit monoclonal antibodies are now available because a good rabbit myeloma cell line is now available. Rabbit monoclonal antibodies have high sensitivity and excellent response to antigens from mouse tissue.
As a result of the popularity of rabbit monoclonal antibodies, confusion exists when using the term monoclonal. Previously, monoclonal antibodies were always from mouse and so detection systems were always based on binding to mouse monoclonal antibodies. Now with the popularity of rabbit monoclonal antibodies, it is not possible to use the term monoclonal to identify the species of the antibody.
Advantages of Monoclonal Antibodies
• Single clone monoclonal antibodies bind to a single epitope, which is selected for high speciﬁcity for the antigen.
• Different clones of antibodies can be generated to different epitopes on a single antigen.
• Single clone can be generated to a posttranscriptionally altered protein (e.g., phosphorylated amino acid).
• Clones to an epitope shared with multiple proteins (gene products) can be rejected.
• The same antibody can be generated indeﬁnitely from cultured hybridoma cells in a process that creates a stable reagent.
• The identical clone sold by different companies will be the same antibody.
Disadvantages of Monoclonal Antibodies
Talking About Antibodies Terminology is important in describing the source and speciﬁcity of antibodies used in immunocytochemistry. The species used to generate antibodies are used to differentiate antibodies. An antibody generated in rabbit to the protein tubulin would be a “rabbit anti-tubulin antibody.” With both mouse and rabbit being used to make monoclonal antibodies, the species of the animal generating the monoclonal antibody must be stated, and not simply “monoclonal” to mean antibodies produced in mouse. To identify an antibody, use the species of animal where the antibody was generated and not the term monoclonal.
Concentrations of IgG in
serum is 1–10 mg/ml; ascites is 1–2 mg/ml; and supernatant is 0.4–1 mg/ml
Antibodies can come in a variety of forms and purities. Polyclonal antibodies can come as whole serum or as puriﬁed antibodies with an IgG concentration of 1 mg/ml. Monoclonal antibodies come as isolated tissue culture media from hybridoma cells called supernatant. The antibody from supernatants is between 50 and 100 μg/ml, which means that the working antibody dilution for immunocytochemistry will be lower than whole serum. In addition, monoclonal antibodies can be ascites ﬂuid giving antibodies that are highly concentrated of 1 mg/ml. Today, generation of ascites may be restricted by federal regulations for care of research animals.
To increase the purity or to concentrate an antibody solution, it may be puriﬁed.
Puriﬁcation is done with a range of techniques applied to whole serum, supernatant, or ascites ﬂuid. At the ﬁrst level, the puriﬁed Ig will be separated from other serum proteins and will select all IgGs including the IgG of interest and other IgG molecules. These puriﬁcation steps can be done by using ammonium sulfate to precipitate the Ig molecules or it can be done by binding antibodies to a Protein A and/or Protein G columns. Proteins A and G are produced by the bacteria, Staphylococcus aureus, and bind to different species and subclasses of antibodies by the Fc receptor. After the antibodies have attached, they are washed out by changing the buffer.